English
Home > Products > Lobeline HCl API

China Lobeline HCl API Factory

Our products are greatly recognized and trustworthy by users and will fulfill continually shifting economic and social requires for Lobeline HCl API,CAS NO:134-63-4,Lobeline API,Lobeline HCl,Lobeline, We adhere on the tenet of "Services of Standardization, to meet Customers' Demands".
Lobeline HCl API, We have been persisting in the business essence "Quality First, Honoring Contracts and Standing by Reputations, providing customers with satisfying merchandise and service. " Friends both at home and abroad are warmly welcome to establish everlasting business relations with us.

Related Products

Hot Products

  • Hexamethonium bromide

    Hexamethonium bromide

    Product Name:Hexamethonium bromide
    Molecular Formula:C12H30Br2N2
    Molecular Weight:362.19
    CAS Registry Number:55-97-0
  • tert-butyl 4-hydroxy-3-methylphenylcarbamate

    tert-butyl 4-hydroxy-3-methylphenylcarbamate

    Product Name:tert-butyl 4-hydroxy-3-methylphenylcarbamate
    Molecular Formula:C12H17NO3
    Molecular Weight:223.27
    CAS Registry Number:218966-28-0
  • 2'-Deoxyadenosine monohydrate

    2'-Deoxyadenosine monohydrate

    Product Name:2'-Deoxyadenosine monohydrate
    Molecular Formula:C10H15N5O4
    Molecular Weight:269.26
    CAS Registry Number:16373-93-6
  • 2-Fluorobenzaldehyde

    2-Fluorobenzaldehyde

    Product Name:2-Fluorobenzaldehyde
    Molecular Formula:C7H5FO
    Molecular Weight:124.11
    CAS Registry Number:446-52-6
  • 1,1-Cyclobutanedicarboxylic acid

    1,1-Cyclobutanedicarboxylic acid

    Product Name:1,1-Cyclobutanedicarboxylic acid
    Molecular Formula:C6H8O4
    Molecular Weight:144.13
    CAS Registry Number:5445-51-2
  • Vericiguat

    Vericiguat

    Product Name:Vericiguat
    Molecular Formula:C19H16F2N8O2
    Molecular Weight;426.38
    CAS Registry Number;1350653-20-1
  • Related Blog
  • Reviews

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept